Cardiol Therapeutics Inc (CRDL)

2.10 +0.13  +6.60% NASDAQ Dec 6, 16:00 2.10 0.00  0.00% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All CRDL News

News

View All Events

Events

Date Type Description
02/15/2022 Earnings Results Q4 2021 Earnings Results
11/15/2021 Earnings Results Q3 2021 Earnings Results
08/16/2021 Earnings Results Q2 2021 Earnings Results
05/17/2021 Earnings Results Q1 2021 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory therapies for cardiovascular disease (CVD). Its lead product, CardiolRx, is a pharmaceutical oral cannabidiol formulation being investigated in a Phase II/III study in hospitalized COVID-19 patients with a prior history of, or risk factors for, CVD. The company has also received clearance for a Phase II international trial of CardiolRx in acute myocarditis, a leading cause of cardiac death in people less than 35 years old.
  • URL: https://www.cardiolrx.com
  • Investor Relations URL: N/A
  • HQ State/Province: Ontario
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Feb. 15, 2022
  • Last Earnings Release: Nov. 15, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.